Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 5 (sodium/glucose cotransporter), member 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Wolbachia endosymbiont of Brugia malayi | phenylalanyl-tRNA synthetase subunit beta | 0.0042 | 0.1841 | 0.5 |
Schistosoma mansoni | methionyl-tRNA synthetase | 0.0042 | 0.1841 | 0.1763 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0096 | 0.5011 | 1 |
Giardia lamblia | Tyrosyl-tRNA synthetase | 0.0054 | 0.2547 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0096 | 0.5011 | 1 |
Toxoplasma gondii | tRNA binding domain-containing protein | 0.0042 | 0.1841 | 0.7229 |
Echinococcus granulosus | solute carrier family 5 | 0.0181 | 1 | 1 |
Treponema pallidum | methionyl-tRNA synthetase | 0.0042 | 0.1841 | 0.5 |
Echinococcus granulosus | sodium coupled monocarboxylate transporter 1 | 0.0046 | 0.2118 | 0.1858 |
Brugia malayi | Kringle domain containing protein | 0.0015 | 0.0319 | 0.0636 |
Plasmodium vivax | sortilin, putative | 0.0016 | 0.0373 | 0.0245 |
Trypanosoma brucei | tyrosyl-tRNA synthetase, putative | 0.0054 | 0.2547 | 1 |
Schistosoma mansoni | sodium/solute symporter | 0.0046 | 0.2118 | 0.2042 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.2118 | 0.4226 |
Entamoeba histolytica | tyrosyl-tRNA synthetase, putative | 0.0054 | 0.2547 | 1 |
Leishmania major | hypothetical protein | 0.0042 | 0.1841 | 0.6833 |
Brugia malayi | GH02984p | 0.0046 | 0.2118 | 0.4226 |
Echinococcus granulosus | tyrosyl tRNA synthetase | 0.0095 | 0.4971 | 0.4805 |
Echinococcus granulosus | sodium:glucose cotransporter 2 | 0.0181 | 1 | 1 |
Trypanosoma cruzi | tyrosyl-tRNA synthetase, putative | 0.0054 | 0.2547 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0015 | 0.0319 | 0.0636 |
Echinococcus granulosus | high affinity choline transporter 1 | 0.0046 | 0.2118 | 0.1858 |
Echinococcus multilocularis | high affinity choline transporter 1 | 0.0046 | 0.2118 | 0.1858 |
Brugia malayi | MH2 domain containing protein | 0.0096 | 0.5011 | 1 |
Mycobacterium ulcerans | phenylalanyl-tRNA synthetase subunit beta | 0.0042 | 0.1841 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0319 | 0.0226 |
Echinococcus granulosus | sortilin | 0.0016 | 0.0373 | 0.0056 |
Echinococcus multilocularis | solute carrier family 5 | 0.0181 | 1 | 1 |
Loa Loa (eye worm) | multisynthetase complex auxiliary component p43 | 0.0042 | 0.1841 | 0.3674 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0042 | 0.1841 | 0.6833 |
Plasmodium vivax | tyrosine--tRNA ligase, putative | 0.0054 | 0.2547 | 1 |
Toxoplasma gondii | kringle domain-containing protein | 0.0015 | 0.0319 | 0.1251 |
Echinococcus multilocularis | sodium:glucose cotransporter 2 | 0.0181 | 1 | 1 |
Leishmania major | tyrosyl or methionyl-tRNA synthetase-like protein | 0.0042 | 0.1841 | 0.6833 |
Schistosoma mansoni | high-affinity choline transporter | 0.0046 | 0.2118 | 0.2042 |
Onchocerca volvulus | 0.0046 | 0.2118 | 1 | |
Chlamydia trachomatis | phenylalanine--tRNA ligase subunit beta | 0.0042 | 0.1841 | 0.5 |
Brugia malayi | methionyl-tRNA synthetase | 0.0042 | 0.1841 | 0.3674 |
Trypanosoma cruzi | tyrosyl or methionyl-tRNA synthetase, putative | 0.0042 | 0.1841 | 0.6833 |
Echinococcus multilocularis | tyrosyl tRNA synthetase | 0.0095 | 0.4971 | 0.4805 |
Leishmania major | tyrosyl-tRNA synthetase, putative | 0.0054 | 0.2547 | 1 |
Plasmodium vivax | methionine-tRNA ligase, putative | 0.0042 | 0.1841 | 0.6833 |
Echinococcus multilocularis | sodium coupled monocarboxylate transporter 1 | 0.0046 | 0.2118 | 0.1858 |
Mycobacterium tuberculosis | Probable phenylalanyl-tRNA synthetase, beta chain PheT | 0.0042 | 0.1841 | 0.5 |
Toxoplasma gondii | transporter, solute:sodium symporter (SSS) family protein | 0.0046 | 0.2118 | 0.8314 |
Echinococcus granulosus | aminoacyl tRNA synthase complex interacting | 0.0042 | 0.1841 | 0.1573 |
Plasmodium falciparum | sortilin | 0.0016 | 0.0373 | 0.0245 |
Brugia malayi | Protein kinase domain containing protein | 0.0015 | 0.0319 | 0.0636 |
Toxoplasma gondii | tRNA synthetases class I family protein | 0.0054 | 0.2547 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0042 | 0.1841 | 0.6833 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0319 | 0.0636 |
Schistosoma mansoni | tyrosyl-tRNA synthetase | 0.0095 | 0.4971 | 0.4923 |
Echinococcus multilocularis | aminoacyl tRNA synthase complex interacting | 0.0042 | 0.1841 | 0.1573 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0042 | 0.1841 | 0.6833 |
Onchocerca volvulus | 0.0015 | 0.0319 | 0.1505 | |
Toxoplasma gondii | sortilin, putative | 0.0016 | 0.0373 | 0.1466 |
Plasmodium falciparum | tRNA import protein tRIP | 0.0042 | 0.1841 | 0.6833 |
Echinococcus multilocularis | sodium:myo inositol cotransporter | 0.0181 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.2118 | 0.4226 |
Echinococcus granulosus | sodium:myo inositol cotransporter | 0.0181 | 1 | 1 |
Trypanosoma cruzi | tyrosyl or methionyl-tRNA synthetase, putative | 0.0042 | 0.1841 | 0.6833 |
Plasmodium falciparum | tyrosine--tRNA ligase | 0.0054 | 0.2547 | 1 |
Schistosoma mansoni | inositol transporter | 0.0181 | 1 | 1 |
Echinococcus multilocularis | sortilin | 0.0016 | 0.0373 | 0.0056 |
Trichomonas vaginalis | isoleucyl, leucyl, tyrosyl, valyl and methionyl-tRNA synthetases, putative | 0.0054 | 0.2547 | 1 |
Schistosoma mansoni | inositol transporter | 0.0181 | 1 | 1 |
Toxoplasma gondii | methionyl-tRNA synthetase | 0.0042 | 0.1841 | 0.7229 |
Brugia malayi | Sodium:solute symporter family protein | 0.0046 | 0.2118 | 0.4226 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 4.5 nM | BindingDB_Patents: Inhibition Assay. The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Company) and cultured at 37 C. under 5% CO2 overnight. The medium was replaced with 100 uL/well of a Na (+) buffer (140 mM choline chloride, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, 5 mM Tris, pH7.4) followed by incubation for 20 minutes at 37 C. under 5% CO2. After removing the Na (+) buffer, a test compound solution which was prepared from Na (+) buffer (140 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, 5 mM Tris, pH7.4) containing BSA was added thereto at 40 uL/well. In addition, Na (+) buffer containing 8 kBq of 14C-AMG and 2 mM AMG was added thereto at 40 uL/well, and was mixed well. Na (+) buffer containing BSA was added to a blank well at 40 uL/well and additionally adding a Na (+) buffer containing 8 kBq of 14C-AMG and 2 mM AMG, and was mixed well. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.